Alpha-Synuclein: The Spark That Flames Dopaminergic Neurons, In Vitro and In Vivo Evidence

Int J Mol Sci. 2022 Aug 30;23(17):9864. doi: 10.3390/ijms23179864.

Abstract

Mitochondria, α-syn fibrils and the endo-lysosomal system are key players in the pathophysiology of Parkinson's disease. The toxicity of α-syn is amplified by cell-to-cell transmission and aggregation of endogenous species in newly invaded neurons. Toxicity of α-syn PFF was investigated using primary cultures of dopaminergic neurons or on aged mice after infusion in the SNpc and combined with mild inhibition of GBA. In primary dopaminergic neurons, application of α-syn PFF induced a progressive cytotoxicity associated with mitochondrial dysfunction, oxidative stress, and accumulation of lysosomes suggesting that exogenous α-syn reached the lysosome (from the endosome). Counteracting the α-syn endocytosis with a clathrin inhibitor, dopaminergic neuron degeneration was prevented. In vivo, α-syn PFF induced progressive neurodegeneration of dopaminergic neurons associated with motor deficits. Histology revealed progressive aggregation of α-syn and microglial activation and accounted for the seeding role of α-syn, injection of which acted as a spark suggesting a triggering of cell-to-cell toxicity. We showed for the first time that a localized SNpc α-syn administration combined with a slight lysosomal deficiency and aging triggered a progressive lesion. The cellular and animal models described could help in the understanding of the human disease and might contribute to the development of new therapies.

Keywords: GBA; Parkinson’s disease; mitochondrial dysfunction; spreading; α-synuclein.

MeSH terms

  • Animals
  • Dopaminergic Neurons / pathology
  • Humans
  • Lysosomes / pathology
  • Mice
  • Nerve Degeneration / pathology
  • Parkinson Disease* / pathology
  • alpha-Synuclein* / genetics

Substances

  • alpha-Synuclein

Grants and funding

All the authors are employees by Neuro-Sys and are paid by the company.